Nevertheless, there are several mucosal molecules/pathways that are currently under investigation as potential therapeutic targets for type 2 low or mixed type of asthma, these include IL‐6 [145 ] and TLR‐3,4,7 [146 ]. Here, IL6 is linked to asthma.